Connect Biopharma, a clinical-stage biopharmaceutical company, has closed $115 million in Series C financing. RA Capital Management led the round with participation from Lilly Asia Ventures, Boxer Capital, HBM Healthcare Investments and Qiming Venture Partners.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: